ICM
BSX icon

ICC Capital Management’s Boston Scientific BSX Stock Holding History

ICC Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$3.27M Sell
184,055
-4,295
-2% -$67.9K 0.43% 86
2014
Q4 		$2.5M Buy
+188,350
New +$2.41M 0.32% 116

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

ICC Capital Management's BSX Position: Q1 2015 in Review

ICC Capital Management reduced its Boston Scientific (BSX) stake by 2.3% in Q1 2015, selling an estimated $67.9K and leaving 184,055 shares worth $3.27M. The position accounts for 0.43% of the portfolio, ranked #86.

ICC Capital Management first reported a position in BSX in Q4 2014 and has held it in 2 quarters since. 471 funds tracked by Wall St. Rank hold BSX as of Q1 2015.

  • ICC Capital Management held 184,055 shares of Boston Scientific worth $3.27M as of Q1 2015.
  • ICC Capital Management sold 4,295 Boston Scientific shares in Q1 2015, an estimated $67.9K.
  • Boston Scientific made up 0.43% of ICC Capital Management's portfolio in Q1 2015, its #86 holding.
  • ICC Capital Management first reported a position in Boston Scientific in Q4 2014 and has held it in 2 quarters since.
  • 471 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2015.

Based on ICC Capital Management's 13F filing for Q1 2015, filed 13 May 2015.